Evaluation of an Amitriptyline-Perphenazine Combination in Chronic Schizophrenia
Abstract
The author describes a controlled study of an amitriptyline-perphenazine combination given to 58 chronic schizophrenic patients. There was no evidence of the combination's increased effectiveness over perphenazine used alone. He discusses the possibility of therapeutic incompatibility between perphenazine and amitriptyline at some dosage levels and concludes that there is no evidence that supports using a perphenazine-amitriptyline combination.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
